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Summary The objective of this randomized, double-blind, placebo-controlled
clinical trial was to determine whether a topical anesthetic agent (tetracaine)
provides effective local analgesia prior to radial arterial puncture. Tetracaine or
placebo gel was applied 45min prior to arterial puncture to patients who were
referred for elective arterial blood gas. The primary outcome was the patient’s
perception of pain associated with the procedure as measured by a visual analog
scale. Fifty patients were randomized into the study, 24 received tetracaine and 26
placebo. Mean pain score on the visual analog scale was 26.2732.6 for the
tetracaine-treated patients and 23.8727.4 for the placebo-treated patients
(P ¼ 0:78). Mean time from the first skin puncture to successful procurement of
1ml of arterial blood was 707103 s in the tetracaine group and 49748 s in the
placebo group (P ¼ 0:40). Difficulty of arterial puncture as assessed by the respiratory
therapist performing the test was identical for the two groups (P ¼ 0:86). We
conclude that tetracaine gel did not decrease patient’s perception of pain associated
with arterial puncture, nor did its use facilitate the ABG procedure.






The arterial blood gas (ABG) is a test that provides
important information on patients’ blood pH,
oxygenation and CO2 elimination.
1 ABGs are most
often done on an urgent or semi-urgent basis in
critically ill patients. However, elective, non-
urgent ABGs are also frequently performed, often
in outpatient clinics or pulmonary function labora-
tories.
Arterial blood is usually obtained by percuta-
neous needle puncture of a palpable radial (wrist)
artery. The procedure can be painful for patients
because it involves puncture of the skin and the
radial artery. Difficulties finding the radial artery
are common, and multiple skin punctures are
sometimes required before a successful ABG is
obtained. Understandably, the pain associated with
the procedure can provoke anxiety, especially in
patients who require serial ABGs for assessment of
their respiratory status.2
The use of local infiltrative anesthetic prior to
arterial puncture is supported by results from two
clinical trials,2,3 and is recommended by the British
Thoracic Society in order to decrease the pain
associated with the procedure.4 However, local
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infiltrative anesthesia produces pain during its
administration, and therefore the use of local
anesthesia prior to arterial puncture has not been
widely adopted by physicians.2
An alternative anesthetic option other than local
infiltration with lidocaine may be topical anes-
thetics. Topical anesthetics, such as tetracaine gel
and lidocaine-prilocaine cream, bind to neuronal
receptor sites in nociceptors below the stratum
corneum and provide effective skin analgesia.5,6
Tetracaine gel also has the added property of acting
in a bi-phasic manner on local blood vessels, and it
may act to vasodilate the radial artery and there-
fore facilitate successful arterial puncture.6
The major advantage to topical anesthetics is
that, unlike local anesthetics, their administration
is painless. The following randomized double-blind,
placebo-controlled clinical trial was undertaken to
determine whether a topical anesthetic agent




Outpatients referred to the pulmonary function lab
for elective ABGs from March to November 2001
were recruited for the study. Four experienced
respiratory therapists, certified and licensed by The
Canadian College of Respiratory Therapists of
Ontario, performed the arterial punctures. All
patients 18 years of age or older were eligible to
participate. Patients were excluded from the study
if they had a history of allergy to local anesthetics,
psoriasis affecting the wrists, or if they were taking
warfarin. The protocol and consent forms were
approved by the Ottawa Hospital Research Ethics
Board.
Study design
The study was a double-blind, randomized, place-
bo-controlled trial. Central computer-generated
randomization lists were prepared. The randomiza-
tion schedule was blocked by four and randomiza-
tion was stratified according to the respiratory
therapist performing the test.
The sample size was calculated to detect a
13mm between-group difference in the visual
analog pain scale score (VAS) with a power of 0.8
and a two-tailed alpha of 0.05. The VAS is a well-
validated tool that is used to measure patient’s
perception of pain associated with venipuncture or
arterial puncture.7 A standard deviation in the VAS
of 15mm was assumed based on two studies which
evaluated subcutaneous anesthetics for pain asso-
ciated with arterial puncture.2,3 A difference of
13mm was chosen because it has been shown to be
the minimal clinically significant difference in pain
scores using the VAS.8 The final a priori calculated
sample size was 44 patients (22 patients per group).
Treatments
After obtaining written informed consent, the
respiratory therapist performed an Allen’s test to
determine which wrist would be used. The chosen
site was prepared by abrading the skin over the
radial area with 3M Red Dot tracing prep paper.
This was done five times to facilitate diffusion of
the gel across the stratum corneum.9 Eligible
patients were randomly assigned to receive treat-
ment with 1 g of tetracaine gel 4%, or placebo gel
that was odorless and identical in appearance and
texture to the tetracaine gel. The gel was applied
to the site of the radial artery pulsation 45min
prior to the arterial puncture and the gel was
covered with an occlusive dressing. After 45min,
the dressing and excess gel was removed and the
skin was cleansed with an alcohol swab. The
respiratory therapist palpated the radial artery
and inserted a 23-guage needle for arterial punc-
ture.
At the time the needle made physical contact
with the patient’s skin a co-worker activated a
stopwatch. The procedure was considered com-
plete as soon as one milliliter of arterial blood was
obtained, and at this point the needle was with-
drawn, and the time on the stopwatch was
recorded.
The individual respiratory therapist was allowed
two puncture attempts. If the second skin puncture
was unsuccessful the procedure was considered to
have ‘failed’ and the time was recorded.
Immediately following the procedure the respira-
tory therapist who performed the ABG left the
room and the co-worker asked the patient to assess
the discomfort that was caused by the puncture.
The patient was asked to place a slash on a 100mm
visual analogue pain score (VAS). The VAS showed
‘‘no pain’’ at 0mm and ‘‘worst pain’’ at 100mm. To
ensure that the patients understood how to use a
VAS they were given practice questions during their
45min wait period that asked them to grade
extremes of temperature on a visual analogue
scale. Their ability to correctly fill out the VAS
was verified before the arterial puncture was
attempted.
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The respiratory therapist documented the diffi-
culty of the arterial puncture by using a graded
points scale, i.e. grade 1¼ easy, grade
2¼moderately difficult, grade 3¼ difficult and
grade 4¼ failed.10
At 24 h patients were asked to report the
presence of any local adverse effects such as
redness, bruising, swelling, or itching, by returning
a self-addressed questionnaire to the coordinating
center.
Data analysis
The primary analysis was performed on all patients
randomized into the study using the intent to treat
principle. VAS pain scores and the time to success-
ful ABG were analyzed using independent t-tests.
The difficulty of the ABG procedure was analyzed
using Somers’ d-test for ordinal data. The propor-
tion of failed ABGs was calculated using the Fisher’s
exact test. All reported P values are two-tailed.
Results
A total of 71 patients who were referred to the
Ottawa Hospital pulmonary function laboratory for
elective ABGs from March to November 2001 were
screened for entry into the study, and 50 patients
were randomized. Among the patients who were
screened but were not randomized, 12 patients
were ineligible because they were taking warfarin,
and 9 patients declined to participate. One patient
who declined to participate had already brought
her own anesthetic cream to the laboratory. The
mean age of the randomized patients was 60713
years, and 34 (68%) were male. Patient baseline
characteristics were evenly distributed between
the two randomized treatment groups (Table 1).
Twenty-four of the patients were randomized to
tetracaine and 26 to placebo gel.
Results of the VASs are shown in Table 2. Lower
scores on the VAS imply less pain. Mean VAS pain
score was 26.2732.6 for the tetracaine-treated
patients and 23.8727.4 for the placebo-treated
patients (P ¼ 0:78).
The difficulty associated with the arterial punc-
ture and the likelihood of successful puncture was
assessed using several outcome measurements. One
of 24 ABGs failed in the tetracaine group, and 3 of
26 failed in the placebo group (P ¼ 0:61). Six of 24
(25%) of the tetracaine-treated patients required
more than one puncture sites for successful ABG,
versus 4 of 26 (15%) in the placebo group
(P ¼ 0:40). The mean time from the first skin
puncture to successful procurement of 1ml of
arterial blood for the ABG was 707103 s in the
tetracaine group and 49748 s in the placebo group
(P ¼ 0:40) (Table 2). Difficulty of arterial puncture
as assessed by the respiratory therapist performing
the test was identical for the two groups. Overall
63% and 62% of the tetracaine and placebo-treated
arterial punctures respectively were graded by the
therapist as ‘easy’, 29% and 27% were graded as
‘moderately difficult’, and 8% and 12% were graded
as ‘difficult’ or ‘failed’ (P ¼ 0:86).
There were no significant differences in
adverse effects associated with tetracaine therapy
(Table 2).
Discussion
The aim of this study was to determine whether the
application of 4% topical tetracaine gel to the wrist
of patients prior to ABG was effective at decreasing
the pain associated with the ABG procedure. The
study was powered, a priori, to detect a difference
in VAS pain scores of 13mm between the two
groups with 80% power. A difference in VAS pain
score of 13 has been previously established to be
the minimal clinically significant difference appre-
ciated by patients.8 Based on our a priori power
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Table 1 Clinical characteristics of the enrolled study
patients.
Tetracaine gel Placebo gel
(n ¼ 24) (n ¼ 26)
Age, yrn 60712 61715
Range 37–79 25–86
Sex, male (%) 16 (67) 18 (69)
Smoking status (%)
Smoker 9 (38) 13 (50)
Ex-smoker 12 (50) 10 (38)
Non-smoker 3 (13) 3 (12)
Pack-year historyn 37726 37727
Previous ABG (%) 7 (29) 3 (12)
Respiratory
diagnosis
Asthma (%) 3 (13) 5 (19)
COPD (%) 5 (21) 7 (27)
Lung cancer (%) 12 (50) 13 (50)
Interstitial lung
disease (%)
0 (0) 1 (4)
Other (%) 4 (16) 0(0)
ABGFarterial blood gas; COPDFchronic obstructive
pulmonary disease.
nMean7SD.
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calculation, the study required 22 patients in each
group to show this difference.
The results of this randomized, placebo-con-
trolled, double-blind clinical trial suggest that
application of tetracaine gel prior to arterial
puncture had no effect at decreasing the pain
associated with the arterial puncture and that
tetracaine did not significantly facilitate procedur-
al success.
It is unlikely that this study was unable to show a
positive outcome because it was under-powered. In
fact, patients in the tetracaine-treated group had
slightly higher VAS pain scores than placebo-treated
patients, indicating that there was not even a trend
towards greater pain relief in tetracaine-treated
patients.
However, one limitation to interpretation of our
study results is that the observed variances around
the VAS score for both the active and placebo-
treated patients were wider than had been
assumed a priori based on results of prior published
trials. We hypothesize that increased pain score
variances may have occurred because of the 45-min
delay between application of the tetracaine gel
and the subsequent ABG procedure. In a proportion
of patients, this 45-min delay accentuated pre-
procedure anticipatory anxiety and this may have
contributed to more variation in patient’s indivi-
dual perception of pain associated with the ABG
procedure.
Tetracaine does have a bi-phasic effect on blood
vessels and potential vasodilatory properties, and
we theorized that prior application of tetracaine
might cause vasodilatation of the radial artery, and
thus facilitate a successful arterial puncture.5,6
However, this effect was not seen; the time to
successful ABG, number of failed ABGs, number of
skin puncture attempts, and difficulty of the ABG,
as assessed by the respiratory therapist performing
the test, were not different in the tetracaine and
placebo-treated groups.
There are two trials in the literature that support
the use of local anesthesia with subcutaneous
lidocaine prior to arterial puncture. One study
randomized 101 patients undergoing arterial punc-
ture to infiltration with 2% lidocaine, infiltration
with normal saline, or no infiltration.2 Significantly
lower pain ratings, assessed by patients and
physicians, were noted in the group that received
lidocaine infiltration compared to the other two
groups. The difficulty of the procedure was not
adversely affected by the use of lidocaine. A similar
study randomized 140 patients to infiltration with
lidocaine versus normal saline.3 This study showed
that mean VAS score was significantly lower in the
group that received lidocaine compared to the
group that received placebo (VAS pain score of
1.5071.54 cm in the licocaine group versus
3.0672.15 cm for the group that received placebo,
P ¼ 0:00001).
Despite its demonstrated efficacy, local infiltra-
tion with lidocaine prior to arterial puncture is not
routinely practiced. A telephone survey of 100
junior hospital physicians established that 84%
never used local anesthetic prior to performing a
radial artery puncture.2 Forty-seven percent of the
100 physicians surveyed considered the injection of
local anesthetic to be as painful as the procedure
itself.
A recent study by Tran et al. has evaluated the
effect of topical amethocaine (tetracaine) 4% in
reducing pain during arterial puncture. This rando-
ARTICLE IN PRESS
Table 2 Study results.
Tetracaine gel Placebo gel P-value
(n ¼ 24) (n ¼ 26)
Visual analog pain scale scoren 26.2732.6 23.8727.4 0.78
Time to successful ABGn (seconds) 707103 49748 0.61
X1 Puncture site (%) 6 (25) 4 (15) 0.40
Successful ABG (%) 23 (96) 23 (88) 0.61
Adverse effects (within 24 h)
Redness 1 1 0.99
Swelling 1 1 0.99
Itching 1 0 0.43
Bruising 0 3 0.25
Any adverse effect 2 (8) 5 (19) 0.44
The visual analog pain scale scores, and the ease of the arterial puncture, were not significantly different in the tetracaine-
treated group as compared to the group which received placebo gel. There were no significant differences in adverse effects
associated with tetracaine therapy.
nMean7SD.
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mized, placebo-controlled trial enrolled 81 pa-
tients and used a design similar to ours. Results of
the Tran study showed that the application of 4%
tetracaine gel applied 30min before radial artery
puncture had no effect on reducing the pain
associated with the procedure.11
It is not obvious why topical tetracaine does not
seem to provide effective analgesia prior to arterial
puncture, however our hypothesis is that a longer
application time may be needed to anesthetize
deeper structures. Previous studies of tetracaine
show that skin analgesia is assured within 45min12
and an application time of 45min is consistent with
the manufacturer’s recommendation for venipunc-
ture. However, the radial artery does lie deeper
under the skin than the superficial veins, and it is
possible that the tetracaine gel did not have
sufficient time to diffuse below the epithelial
basement membrane in a sufficient concentration
gradient to anesthetize deeper pain fibers sur-
rounding the artery.
In conclusion, our study has shown that tetra-
caine gel applied for 45min after tape stripping,
did not provide improved analgesia or facilitate
arterial puncture compared to placebo. Further
studies, with longer anesthetic application times,
may be needed to confirm our results. In the
meantime, clinicians who use local anesthetics
prior to arterial puncture should choose infiltration
with 2% lidocaine since this is the only method of
analgesia that has thus far been proven to be
effective in randomized controlled trials.
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